27
Views
8
CrossRef citations to date
0
Altmetric
Case Report

Patient with neonatal-onset chronic hepatitis presenting with mevalonate kinase deficiency with a novel MVK gene mutation

, , , , , , , , , , , & show all
Pages 641-645 | Received 24 Nov 2010, Accepted 22 Feb 2011, Published online: 02 Jan 2014

References

  • Drenth JP, Denecker NE, Prieur AM, van der Meer JW. Hyper-immunoglobulin D syndrome. Presse Med. 1995;24:1211–3.
  • Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.
  • Sogo T, Fujisawa T, Inui A, Komatsu H, Etani Y, Tajiri H, et al. Intravenous methylprednisolone pulse therapy for children with autoimmune hepatitis. Hepatol Res. 2006;34:187–92.
  • Houten SM, Wanders RJA, Waterham HR. Biochemical and genetic aspects of mevalonate kinase and its deficiency. Biochim Biophys Acta. 2000;1529:19–32.
  • Simon A, Kremer HPH, Wevers RA, Scheffer H, de Jong JG, van der Meer JWM, et al. Mevalonate kinase deficiency: evidence for a phenotypic continuum. Neurology. 2004;62:994–7.
  • Kage M. Pathology of autoimmune liver diseases in children. Hepatol Res. 2007;37:5502–8.
  • Manns MP, Czaja AJ, Gorham JD, Krawitt El, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193–213.
  • Topaloglu R, Ayaz NA, Waterham HR, Yuce A, Gumruk F, Sanal 0. Hyperimmunoglobulinemia D and periodic fever syn-drome; treatment with etanercept and follow-up. Clin Rheumatol. 2008;27:1317–20.
  • Hinson DD, Rogers ZR, Hoffmann GF, Schachtele M, Fingerhut R, Kohlschtter A, et al. Hematological abnormalities and chole-static liver disease in two patients with mevalonate kinase defi-ciency. Am J Med Genet. 1998;78:408–12.
  • Komatsu M, Takahashi T, Uemura N, Takada G. Familial Med-iterranean fever medicated with an herbal medicine in Japan. Pediatr Int. 2004;46:81–4.
  • Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9:473–83.
  • Stojanov S, Lohse P, Lohse P, Hoffmann F, Renner ED, Zellerer S, et al. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmu-noglobulinemia D with periodic fever syndrome: a low-pene-trance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa. Arthritis Rheum. 2004;50:1951–8.
  • Van der Hi1st JC, Bodar RI, Barron KS, Frenkel J, Drenth JP, van der Meer JW, International HIDS Study Group, et al. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore). 2008;87: 301–10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.